Schizophrenia Bulletin vol. 35 no. 2 pp. 443–457, 2009 doi:10.1093/schbul/sbn018 Advance Access publication on April 15, 2008 Antipsychotic Combinations vs Monotherapy…

Slide 1Dose Escalating Safety Study of a New Oral Direct Thrombin Inhibitor, Dabigatran Etexilate, in Patients Undergoing Total Hip Replacement: BISTRO I Eriksson BI, Dahl…

Slide 1 Firman Peter Kabo CARDIOLOGY AND VASCULAR DEPARTMENT MEDICAL FACULTY OF HASANUDDIN UNIVERSITY 2013 Objectives This study was to determine whether colchicine 0.5 mg/day…

Slide 1 Dopo i grandi trial sui NAO: studi post-marketing,registri e dati dal mondo reale Dr. Claudio Fresco Responsabile Scientifico Dipartimento Scienze Cardiopolmonari,…

OASIS-5 The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes trial US hospital discharges in ACS AHA. Heart Disease and Stroke Statistics–2005 Update.…

OASIS-5 The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes trial US hospital discharges in ACS AHA. Heart Disease and Stroke Statistics–2005 Update.…

3 Lebrikizumab Treatment in Adults with Asthma Jonathan Corren, M.D., Robert F. Lemanske, Jr., M.D., Nicola A. Hanania, M.D., Phillip E. Korenblat, M.D., Merdad V. Parsey,…

Dose Escalating Safety Study of a New Oral Direct Thrombin Inhibitor, Dabigatran Etexilate, in Patients Undergoing Total Hip Replacement: BISTRO I Eriksson BI, Dahl OE, Ahnfelt…

Welcome Ask The Experts March 24-27, 2007 New Orleans, LA Christopher P. Cannon, MD Senior Investigator, TIMI Study Group Cardiovascular Division Brigham and Women's…

Mega JL, et al. N Engl J Med 2009;360:354-62 Genetic Effects on Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel Mega JL, et al. N Engl J Med 2009;360:354-62…